This brand name is authorized in Ireland, Spain, UK.
The drug SEHCAT contains one active pharmaceutical ingredient (API):
1
|
UNII
5E090O0G3Z - TAUROCHOLIC ACID
|
|
Tauroselcholic acid is a bile acid analogue which shows identical physiological behaviour with naturally occurring bile acid conjugates. At the chemical concentrations and activities used for diagnostic procedures [75Se]tauroselcholic acid does not appear to exert any pharmacodynamic effects. It is used for the investigation of bile acid malabsorption and measurement of bile acid pool loss. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| SEHCAT Capsule, hard | MPI, EU: SmPC | Health Products Regulatory Authority (IE) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| V09DX01 | Selenium (75Se) tauroselcholic acid | V Various → V09 Diagnostic radiopharmaceuticals → V09D Hepatic and reticulo endothelial system → V09DX Other hepatic and reticulo endothelial system diagnostic radiopharmaceuticals |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| ES | Centro de información online de medicamentos de la AEMPS | 72005 |
| GB | Medicines & Healthcare Products Regulatory Agency | 398570 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.